Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mulvihill

Showing results (11-20 of 178) with videos related to

Pageof 18
Sort By:
Journal of Dental Education|March 1, 1976
Barriers to identification and motivation of minority group members for dentistryJ E Mulvihill
Lancet (London, England)|August 17, 1985
Ciprofloxacin-resistant Staphylococcus aureusH Humphreys, E Mulvihill
Journal of Medical Education|April 1, 1978
A prototype 'fifth pathway' program for Americans studying abroadJ E Mulvihill, F Rosner
Trends in Endocrinology and Metabolism: TEM|August 10, 2024
Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist-based therapiesArianne Morissette, Erin E Mulvihill
Health Affairs (Project Hope)|January 1, 1989
Preventing occupational diseaseJ E Mulvihill, E Storey
New York State Journal of Medicine|November 1, 1980
Supervised clinical clerkship (fifth pathway); effectiveness of program as measured by NBME Part IIF Rosner, J E Mulvihill
JAMA|February 16, 1979
American foreign medical graduates. Performance after a year of supervised clinical clerkships (fifth pathway)F Rosner, J E Mulvihill
New York State Journal of Medicine|April 1, 1979
Americans studying medicine abroad. Six years' experience with supervised clinical year of training "Fifth Pathway")J E Mulvihill, F Rosner
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|June 21, 2024
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approachesArianne Morissette, Erin E Mulvihill
Endocrine Reviews|September 13, 2014
Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitorsErin E Mulvihill, Daniel J Drucker
Pageof 18

Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Journal of Dental Education|March 1, 1976
Barriers to identification and motivation of minority group members for dentistryJ E Mulvihill
Lancet (London, England)|August 17, 1985
Ciprofloxacin-resistant Staphylococcus aureusH Humphreys, E Mulvihill
Journal of Medical Education|April 1, 1978
A prototype 'fifth pathway' program for Americans studying abroadJ E Mulvihill, F Rosner
Trends in Endocrinology and Metabolism: TEM|August 10, 2024
Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist-based therapiesArianne Morissette, Erin E Mulvihill
Health Affairs (Project Hope)|January 1, 1989
Preventing occupational diseaseJ E Mulvihill, E Storey
New York State Journal of Medicine|November 1, 1980
Supervised clinical clerkship (fifth pathway); effectiveness of program as measured by NBME Part IIF Rosner, J E Mulvihill
JAMA|February 16, 1979
American foreign medical graduates. Performance after a year of supervised clinical clerkships (fifth pathway)F Rosner, J E Mulvihill
New York State Journal of Medicine|April 1, 1979
Americans studying medicine abroad. Six years' experience with supervised clinical year of training "Fifth Pathway")J E Mulvihill, F Rosner
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|June 21, 2024
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approachesArianne Morissette, Erin E Mulvihill
Endocrine Reviews|September 13, 2014
Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitorsErin E Mulvihill, Daniel J Drucker
Pageof 18